On the other hand, the rs6129767*G intronic variant might increase PLC-γ1 expression or introduce gain-of-function effects causing enhanced PLC signaling that increases the risk for inflammation and atherosclerosis leading to CHD. The gene discussed is PLCG1; the disease is atherosclerosis.